Dr. Reddy’s Laboratories Ltd.’s Announces The Launch Of Amlodipine Besylate And Atorvastatin Calcium Tablets

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Amlodipine Besylate and Atorvastatin Calcium Tablets 2.5/10mg, 2.5/20mg, 2.5/40mg, 5/10mg, 5/20mg, 5/40mg, 5/80mg, 10/10mg, 10/20mg, 10/40mg and 10/80 mg a therapeutic equivalent generic version of CADUET® (amlodipine Besylate and atorvastatin calcium) tablets, in the US market on March 26, 2014, following the approval by the United States Food & Drug Administration (USFDA).

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC